Asia
Mimicking how the biological world arranges itself could help advance the next generation of nanomaterials.
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
The government shutdown threw a wrench into several biotech company’s plans for initial public offerings (IPOs). Although the government is only guaranteed to stay open until February 15, several biotechs are working to get their IPOs launched in that window. Here’s a look.
Takeda Pharmaceutical released data from its Phase IIIb/IV clinical trial for Adynovate. On the same day, jurors in a Delaware federal court ordered Takeda’s Baxalta unit to pay $155.19 million to Bayer AG for infringing a patent for Adynovate.
Suven Life Sciences Limited announced its Un-audited financial results for the quarter ended 31st December 2018.
China represents the largest market for baby food globally
Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business, announced that Teijin’s board of directors has elected Ichiro Watanabe, currently corporate officer of the Teijin Group, as its next president.
Eisai Co. and Purdue Pharma presented data at the Sleep Research Society’s Conference regarding their lemborexant for the treatment of insomnia. The meeting was held in Clearwater Beach, Florida.
Leading provider of premium medical devices and hygiene products successfully launchesSuprasorb® CNP P3 and Debrisoft Pad for the first time in the region
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
PRESS RELEASES